文献速递神经肌肉病

脊髓延髓肌萎缩症中肌肉而非神经元生物标志物与疾病严重程度相关

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
PubMed 文献 · Neurology · 2019-02-20

该多中心纵向前瞻性研究检测了脊髓延髓肌萎缩症(SBMA)患者血浆/血清神经丝轻链(NfL)、肌酸激酶(CK)和肌酐水平,发现NfL在SBMA中正常且与病情无关,而肌酐显著降低并与疾病严重程度强相关,CK虽升高但无相关性。

要点

  • SBMA患者血NfL水平正常且24个月内稳定,与临床严重程度无关。
  • 肌酐在SBMA中显著降低,与疾病严重程度强相关,可作为有价值的生物标志物。
  • CK在SBMA中升高但与临床指标不相关,提示骨骼肌原发受累。

核心结论

  • SBMA中轴索损伤标志物NfL未改变,而肌肉损伤和肌肉质量标志物异常,提示骨骼肌在疾病发病机制中起主要作用。
  • 肌酐而非CK与疾病严重程度相关,确认其作为SBMA有价值生物标志物的角色。

研究设计与样本

  • 多中心纵向前瞻性研究,纳入英国伦敦(n=50)和意大利帕多瓦(n=43)两个SBMA患者队列,并设肌萎缩侧索硬化(ALS)和健康对照。
  • 检测血浆和血清NfL、CK和肌酐水平,采用SBMA功能评定量表和成人肌病评估工具在基线及12、24个月评估疾病严重程度。

主要发现

  • ALS样本血NfL浓度升高,但两个SBMA队列中NfL均未改变,12和24个月后保持稳定,且与临床严重程度不相关。
  • 在成熟的SBMA小鼠模型中亦发现NfL水平正常。
  • SBMA中CK浓度较ALS样本显著升高,但与临床指标不相关。
  • SBMA中肌酐浓度显著降低,并与疾病严重程度强且显著相关。

临床怎么用

  • 肌酐可作为SBMA疾病严重程度的生物标志物,NfL不适用于SBMA病情监测。
  • CK虽在SBMA中升高,但不建议作为严重程度评估指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether blood biomarkers of neuronal damage (neurofilament light chain [NfL]), muscle damage (creatine kinase [CK]), and muscle mass (creatinine) are altered in spinal and bulbar muscular atrophy (SBMA) and can be used as biomarkers for disease severity. METHODS: In this multicenter longitudinal prospective study, plasma and serum were collected from 2 cohorts of patients with SBMA in London, United Kingdom (n = 50), and Padova, Italy (n = 43), along with disease (amyotrophic lateral sclerosis [ALS]) and healthy controls, and levels of plasma and serum NfL, CK, and creatinine were measured. Disease severity was assessed by the SBMA Functional Rating Scale and the Adult Myopathy Assessment Tool at baseline and 12 and 24 months. RESULTS: Blood NfL concentrations were increased in ALS samples, but were unchanged in both SBMA cohorts, were stable after 12 and 24 months, and were not correlated with clinical severity. Normal NfL levels were also found in a well-established mouse model of SBMA. Conversely, CK concentrations were significantly raised in SBMA compared with ALS samples, and were not correlated to the clinical measures. Creatinine concentrations were significantly reduced in SBMA, and strongly and significantly correlated with disease severity. CONCLUSIONS: While muscle damage and muscle mass biomarkers are abnormal in SBMA, axonal damage markers are unchanged, highlighting the relevant primary role of skeletal muscle in disease pathogenesis. Creatinine, but not CK, correlated with disease severity, confirming its role as a valuable biomarker in SBMA.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lombardi V, Querin G, Ziff OJ, et al. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 2019. PMID: 30787165. doi:10.1212/WNL.0000000000007097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。